AKRO logo

Akero Therapeutics (AKRO) Current liabilities

annual current liabilities:

$39.75M+$20.63M(+107.83%)
December 31, 2024

Summary

  • As of today (June 17, 2025), AKRO annual total current liabilities is $39.75 million, with the most recent change of +$20.63 million (+107.83%) on December 31, 2024.
  • During the last 3 years, AKRO annual current liabilities has risen by +$14.63 million (+58.21%).
  • AKRO annual current liabilities is now at all-time high.

Performance

AKRO Current liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAKRObalance sheet metrics

quarterly current liabilities:

$42.44M+$2.69M(+6.75%)
March 31, 2025

Summary

  • As of today (June 17, 2025), AKRO quarterly total current liabilities is $42.44 million, with the most recent change of +$2.69 million (+6.75%) on March 31, 2025.
  • Over the past year, AKRO quarterly current liabilities has increased by +$12.18 million (+40.25%).
  • AKRO quarterly current liabilities is now -1.97% below its all-time high of $43.29 million, reached on September 30, 2024.

Performance

AKRO quarterly current liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAKRObalance sheet metrics

Current liabilities Formula

Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities

AKRO Current liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+107.8%+40.3%
3 y3 years+58.2%+92.1%
5 y5 years+324.3%+412.2%

AKRO Current liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+108.3%-2.0%+154.5%
5 y5-yearat high+324.3%-2.0%+412.2%
alltimeall timeat high>+9999.0%-2.0%+1712.1%

AKRO Current liabilities History

DateAnnualQuarterly
Mar 2025
-
$42.44M(+6.8%)
Dec 2024
$39.75M(+107.8%)
$39.75M(-8.2%)
Sep 2024
-
$43.29M(+38.9%)
Jun 2024
-
$31.17M(+3.0%)
Mar 2024
-
$30.26M(+58.2%)
Dec 2023
$19.13M(+0.2%)
$19.13M(-32.8%)
Sep 2023
-
$28.45M(+31.7%)
Jun 2023
-
$21.60M(+29.5%)
Mar 2023
-
$16.68M(-12.6%)
Dec 2022
$19.08M(-24.1%)
$19.08M(-24.4%)
Sep 2022
-
$25.24M(-5.4%)
Jun 2022
-
$26.70M(+20.8%)
Mar 2022
-
$22.10M(-12.1%)
DateAnnualQuarterly
Dec 2021
$25.13M(+91.7%)
$25.13M(+6.7%)
Sep 2021
-
$23.54M(+43.0%)
Jun 2021
-
$16.46M(+62.4%)
Mar 2021
-
$10.14M(-22.7%)
Dec 2020
$13.11M(+39.9%)
$13.11M(+9.1%)
Sep 2020
-
$12.01M(+15.6%)
Jun 2020
-
$10.39M(+25.4%)
Mar 2020
-
$8.29M(-11.6%)
Dec 2019
$9.37M(+300.0%)
$9.37M(+39.3%)
Sep 2019
-
$6.72M(+41.9%)
Jun 2019
-
$4.74M(+97.2%)
Mar 2019
-
$2.40M(+2.6%)
Dec 2018
$2.34M(+955.0%)
$2.34M
Dec 2017
$222.00K
-

FAQ

  • What is Akero Therapeutics annual total current liabilities?
  • What is the all time high annual current liabilities for Akero Therapeutics?
  • What is Akero Therapeutics annual current liabilities year-on-year change?
  • What is Akero Therapeutics quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for Akero Therapeutics?
  • What is Akero Therapeutics quarterly current liabilities year-on-year change?

What is Akero Therapeutics annual total current liabilities?

The current annual current liabilities of AKRO is $39.75M

What is the all time high annual current liabilities for Akero Therapeutics?

Akero Therapeutics all-time high annual total current liabilities is $39.75M

What is Akero Therapeutics annual current liabilities year-on-year change?

Over the past year, AKRO annual total current liabilities has changed by +$20.63M (+107.83%)

What is Akero Therapeutics quarterly total current liabilities?

The current quarterly current liabilities of AKRO is $42.44M

What is the all time high quarterly current liabilities for Akero Therapeutics?

Akero Therapeutics all-time high quarterly total current liabilities is $43.29M

What is Akero Therapeutics quarterly current liabilities year-on-year change?

Over the past year, AKRO quarterly total current liabilities has changed by +$12.18M (+40.25%)
On this page